Patterns of Loss of Heterozygosity at 10q23.3 and Microsatellite Instability in Endometriosis, Atypical Endometriosis, and Ovarian Carcinoma Arising in Association With Endometriosis
article
OA: closed
CC0
⤵ 46 in-corpus citations
Abstract
Genetic aberrations, such as loss of heterozygosity (LOH) and mutations leading to functional inactivation of the PTEN tumor suppressor gene, located on chromosome 10q23.3, have been shown to be associated with approximately one third of ovarian adenocarcinomas. In addition, microsatellite instability (MSI) leading to the functional inactivation of the PTEN gene has also been reported for ovarian adenocarcinomas with frequencies varying from 6 to 37%. However, the frequency of PTEN gene abnormalities has not been well studied or evaluated in lesions such as typical and atypical endometriosis. The aim of this study was to investigate a possible sequential progression from endometriosis through atypical endometriosis to ovarian carcinoma by assessing LOH at 10q23.3 and MSI in those entities. Genomic DNA was analyzed for LOH and MSI at 3 loci on chromosome 10, using polymerase chain reaction amplification. Significant differences in LOH were seen between endometriosis (4.3%) and ovarian carcinoma (23.5%) at D10S608. The differences at the other 2 loci were not significant. A high frequency of MSI was found in endometriosis (82.6%) and atypical endometriosis (75%); however, the differences were not significant. These results suggest that LOH at D105608 may possibly be an important molecular event in the progression of endometriosis to carcinoma. This study highlights that endometriosis and atypical endometriosis might act as precursor lesions that have the potential to progress into ovarian adenocarcinoma.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- <b>Ovarian atypical endometriosis: its close association with malignant epithelial tumours</b> via openalex
- Cancer risk after a hospital discharge diagnosis of endometriosis via openalex
- ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN via openalex
- Endometrioid Adenocarcinoma of the Ovary and Its Relationship to Endometriosis via openalex
- Endometriosis and ovarian cancer via openalex
- Endometriosis-Associated Ovarian Carcinoma (EAOC): An Entity Distinct from Other Ovarian Carcinomas as Suggested by a Nested Case-Control Study via openalex
- Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. via openalex
- MALIGNANT TUMORS ARISING IN ENDOMETRIOSIS via openalex
- MALIGNANT TUMORS ARISING IN ENDOMETRIOSIS via openalex
- Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. via openalex
- Ovarian Endometriosis Associated with Ovarian Carcinoma: A Clinicopathological and Immunohistochemical Study via openalex
- Ovarian tumors associated with atypical endometriosis via openalex
- Possible involvement of <i>hMLH1, p16</i><sup><i>INK4a</i></sup> and <i>PTEN</i> in the malignant transformation of endometriosis via openalex
- Prognostic Importance of Hyperplasia and Atypia in Endometriosis via openalex
- Role of Endometriosis in Cancer and Tumor Development via openalex
- Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer via openalex
- W1976469040 via openalex
- W2079587232 via openalex
- W2084951351 via openalex
- W2090116402 via openalex
- W2091340273 via openalex
- W2093672571 via openalex
- W2103902293 via openalex
- W2110503511 via openalex
- W2143130491 via openalex
- W2148310694 via openalex
- W2150233389 via openalex
- W1593108703 via openalex
- W2154546296 via openalex
- W1506338733 via openalex
- W2312585383 via openalex
- W2320953740 via openalex
- W2409399764 via openalex
- W2018009295 via openalex
- W1505255521 via openalex
- W2027811142 via openalex
- W1999128031 via openalex
- W2043177767 via openalex
- W2055058249 via openalex
- W1995819860 via openalex
Cited by (46)
- New Evidence About Malignant Transformation of Endometriosis—A Systematic Review 2025
- Ovarian Endometrioid and Clear-Cell Tumors 2025
- Ovarian Endometrioid and Clear-Cell Tumors 2024
- Atypical endometriosis: a review of an incompletely understood putative precursor of endometriosis-associated ovarian carcinoma 2023
- KRAS Mutation in Endometriosis-Associated Ovarian Borderline and Malignant Epithelial Tumors 2022
- Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms—Review 2022
- Endometrioid Carcinoma Arising from an Endometriosis-Associated Abdominal Wall Scar 2020
- Ovarian Endometrioid and Clear-Cell Tumors 2019
- Hepatocyte nuclear factor-1 beta protects endometriotic cells against apoptotic cell death by up-regulating the expression of antiapoptotic genes† 2019
- Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology 2019
- Concomitant endometriosis in malignant and borderline ovarian tumours* 2018
- Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis 2018
- Endometriosis — insights into a multifaceted entity 2018
- Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development 2018
- Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients 2018
- Clear Cell Carcinoma of the Ovary 2017
- Clinical implication for endometriosis associated with ovarian cancer 2017
- BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer 2016
- Endometriosis research using capture microdissection techniques: Progress and future applications 2016
- Precancerous Lesions of Ovarian Clear Cell and Endometrioid Carcinomas 2015
- Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (Review) 2014
- Cellular, Histologic, and Molecular Changes Associated With Endometriosis and Ovarian Cancer 2013
- Endometriosis, Leiomyoma and Adenomyosis: the Risk of Gynecologic Malignancy 2013
- Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms 2012
- Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma 2012
- Involvement of pelvic inflammation–related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis 2012
- Multiple Synchronous Primary Gynecologic Malignancies in an <i>MSH2</i> Mutation Carrier With Endometriosis 2012
- The Dichotomy in the Histogenesis of Endometriosis-associated Ovarian Cancer 2012
- Clinical Management of Ovarian Endometriotic Cyst (Chocolate Cyst): Diagnosis, Medical Treatment, and Minimally Invasive Surgery 2012
- Unraveling the two entities of endometrioid ovarian cancer: A single center clinical experience 2012
- Chromosomal Aberrations Detected by Chromogenic In Situ Hybridization in Abdominal Wall Endometriosis After Cesarean Section 2012
- Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis 2011
- Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development 2011
- Relationship between endometriosis and cancer from current perspective 2011
- Signaling Pathways in Endometriosis (Eutopic/Ectopic) 2011
- The emerging role of epigenetics in the aetiology of endometriosis. 2011
- Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis 2010
- Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management 2009
- Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review) 2009
- Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective 2008
- Prognostic implication of endometriosis in clear cell carcinoma of the ovary 2008
- Primary sex cord‐like variant of endometrioid adenocarcinoma arising from endometriosis 2008
- XRCC4 codon 247*A and XRCC4 promoter −1394*T related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis 2008
- Pelvic Endometriosis is Rarely Associated with Ovarian Borderline Tumours, Cytologic and Architectural Atypia: A Clinicopathologic Study 2008
- Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis 2008
- Atypical endometriosis: a clinicopathologic study of 163 cases 2007
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:18.313808+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK